Alexander Schauss, Ph.D. Speaks At New Ingredient Track Seminar
(New York, NY) March 2, 2005 – Alexander Schauss, Ph.D., director, of AIBMR, Inc. and leading scientific expert on the health benefits of Cognizin™ citicoline, joins the roster of distinguished speakers at Nutracon. Dr. Schauss will discuss the Recently Discovered Health Benefits of Citicoline at the Nutracon New Ingredient Science Track Seminar, Thursday, March 17 from 4:15 to 5 p.m. The seminar is located in Room 303A in the Anaheim Convention Center.
Learn about the pharmacokinetic technology to improve memory and cognitive function, and the ability of Cognizin™ to replenish the brain with key nutrients and provide a protective effect by preserving the integrity of neuronal membranes.
Cognizin™, developed by Kyowa Hakko using their proprietary fermentation technology, is a novel and powerful anti-aging ingredient that has been used extensively for the treatment of neurodegenerative disorders associated with stroke, cerebrovascular pathology, brain aging, and head trauma. Scientific studies have indicated effectiveness in treating Alzheimer’s and Parkinson’s disease and improved stroke recuperation, as well as ocular health.
For more information regarding this presentation please call (800) 570-1262 or visit the web site at www.Cognizin.com. Visit Kyowa Hakko U.S.A., one of the world leaders in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products will exhibit at SupplyExpo, Hall A, booth 438.
# # # #
For more information:
Baker Dillon Group